unknown
Stage
4
Investors
About
RiboxX GmbH is a biotech company specializing in the development and production of synthetic RNA molecules, including mRNA and siRNA. They offer RNA synthesis services for therapeutic and diagnostic applications such as vaccine development, gene therapy, and drug discovery.
Explore RiboxX GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.